Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trulieve Cannabis (TCNNF) EBITDA Margin (2020 - 2025)

Trulieve Cannabis has reported EBITDA Margin over the past 6 years, most recently at 5.22% for Q4 2025.

  • Quarterly results put EBITDA Margin at 5.22% for Q4 2025, up 478.0% from a year ago — trailing twelve months through Dec 2025 was 12.15% (up 391.0% YoY), and the annual figure for FY2025 was 16.64%, up 652.0%.
  • EBITDA Margin for Q4 2025 was 5.22% at Trulieve Cannabis, down from 14.66% in the prior quarter.
  • Over the last five years, EBITDA Margin for TCNNF hit a ceiling of 40.33% in Q1 2021 and a floor of 103.37% in Q2 2023.
  • Median EBITDA Margin over the past 5 years was 13.63% (2022), compared with a mean of 6.8%.
  • Biggest five-year swings in EBITDA Margin: crashed -12299bps in 2023 and later soared 11977bps in 2024.
  • Trulieve Cannabis' EBITDA Margin stood at 4.07% in 2021, then tumbled by -66bps to 6.76% in 2022, then skyrocketed by 65bps to 2.38% in 2023, then surged by 118bps to 0.43% in 2024, then soared by 1101bps to 5.22% in 2025.
  • The last three reported values for EBITDA Margin were 5.22% (Q4 2025), 14.66% (Q3 2025), and 17.42% (Q2 2025) per Business Quant data.